• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
GH Research released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.226 (forecast USD -0.235)
04:00
GH Research released FY2025 9 Months earnings on November 6 (EST), actual revenue USD 0, actual EPS USD -0.562
04:00
Nov6
GH Research plc updates its clinical pipeline, showing significant results for candidate drug GH001 in Phase 2b trials
12:09
Oct17
GH Research plc Announces Clinical Trial Results for GH001 in Treatment of Treatment-Resistant Depression
11:03
Oct13
Needham Gives GH Research PLC Drug GH-001 a Buy Rating
18:17
Oct9
GH Research PLC Accepts Invitation to New Therapy Workshop
12:10

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -14.02 M, EPS -0.226

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.289 M, EPS -0.1497

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.81 M, EPS -0.1863

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More